{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Chromomycin_A3",
  "nciThesaurus": {
    "casRegistry": "7059-24-7",
    "chebiId": "CHEBI:34638",
    "chemicalFormula": "C57H82O26",
    "definition": "A glycosidic antineoplastic antibiotic isolated from the bacterium Streptomyces griseus.  Chromomycin A3 reversibly binds to guanine-cytosine (G-C) base pairs in the minor groove of DNA, thereby inhibiting RNA synthesis.  This agent is used as a fluorescent chromosome dye.",
    "fdaUniiCode": "DVW027E7NL",
    "identifier": "C895",
    "preferredName": "Chromomycin A3",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [
      "C2115",
      "C371"
    ],
    "synonyms": [
      "3B-O-(4-O-Acetyl-2,6-dideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-7-methylolivomycin D",
      "Aburamycin B",
      "Antibiotic 69895 A",
      "Antibiotic B 599",
      "Antibiotic from Streptomyces griseus",
      "CHROMOMYCIN A3",
      "Chromomycin A3",
      "Olivomycin D, 3B-O-(4-O-Acetyl-2, 6-dideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-7-methyl- (9CI)",
      "Olivomycin D, 3B-O-(4-O-acetyl-2, 6-dideoxy-3-C-methyl-.alpha.-L-arabino-hexopyranosyl)-7-methyl- (9CI)",
      "TOYOMYCIN",
      "Toyomycin"
    ]
  }
}